HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans Lentzen Selected Research

mistletoe lectin I

1/2019Comparison of microbial and transient expression (tobacco plants and plant-cell packs) for the production and purification of the anticancer mistletoe lectin viscumin.
8/2008Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: a study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hans Lentzen Research Topics

Disease

7Neoplasms (Cancer)
01/2019 - 08/2008
3Glioma (Gliomas)
01/2019 - 02/2017
3Glioblastoma (Glioblastoma Multiforme)
01/2019 - 02/2017
1Brain Neoplasms (Brain Tumor)
01/2019
1Pruritus (Itching)
01/2014
1Melanoma (Melanoma, Malignant)
01/2014

Drug/Important Bio-Agent (IBA)

6Viscum ribosome inactivating proteinIBA
01/2019 - 08/2008
3viscum album peptide (Iscador)IBA
01/2019 - 02/2017
2LectinsIBA
01/2019 - 02/2017
2mistletoe lectin IIBA
01/2019 - 08/2008
1Monoclonal AntibodiesIBA
01/2019
1CarbohydratesIBA
01/2019
1CytokinesIBA
01/2018
1Temozolomide (Temodar)FDA LinkGeneric
01/2018
1Pharmaceutical PreparationsIBA
01/2014

Therapy/Procedure

6Therapeutics
01/2019 - 07/2011
2Drug Therapy (Chemotherapy)
01/2019 - 08/2008